NDA 21084, held by US Army Med Res. Perfluoropolymethylisopropyl Ether; Polytetrafluoroethylene.
As of Nov 14, 2026, NDA 21084 (Skin Exposure Reduction Paste Against Chemical Warfare Agents), held by US Army Med Res, was first approved by FDA on Feb 17, 2000, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 17, 2000 | Original applicationNew molecular entity, new combination · Priority review | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Skin Exposure Reduction Paste Against Chemical Warfare Agents50%;50% · paste;topical | Perfluoropolymethylisopropyl Ether; Polytetrafluoroethylene | Discontinued |
| May 6, 2002 | Supplement 1Manufacturing · Priority review | Approved | None posted |
| Feb 17, 2000 | Original applicationNew molecular entity, new combination · Priority review | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
